Format

Send to

Choose Destination
See comment in PubMed Commons below
Ugeskr Laeger. 2013 Apr 22;175(17):1181-5.

[Treatment of adrenocortical carcinomas is challenging].

[Article in Danish]

Author information

1
Onkologisk Klinik 5073, Rigshospitalet, 2100 København Ø, Denmark.

Abstract

Adrenocortical carcinomas (ACC) are rare tumours responsible for only 0.02% of the total number of malignant diseases. However the ACC are aggressive with a mean fiveyears survival of 20-50% and are often associated with increased production of adrenocortical hormones. The effect of the treatment is controversial and often based on small retrospective series or expert opinions. Centralization, international attention and collaboration in the treatment of ACC are mandatory. Randomized clinical trials are needed to determine the best treatment strategy in order to increase survival in patients with ACC.

PMID:
23651782
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Loading ...
    Support Center